D. De Vos

801 total citations
55 papers, 608 citations indexed

About

D. De Vos is a scholar working on Organic Chemistry, Oncology and Spectroscopy. According to data from OpenAlex, D. De Vos has authored 55 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 10 papers in Oncology and 9 papers in Spectroscopy. Recurrent topics in D. De Vos's work include Inorganic and Organometallic Chemistry (6 papers), Organometallic Compounds Synthesis and Characterization (5 papers) and Chemical Thermodynamics and Molecular Structure (5 papers). D. De Vos is often cited by papers focused on Inorganic and Organometallic Chemistry (6 papers), Organometallic Compounds Synthesis and Characterization (5 papers) and Chemical Thermodynamics and Molecular Structure (5 papers). D. De Vos collaborates with scholars based in Netherlands, Belgium and United Kingdom. D. De Vos's co-authors include J. Wolters, Sergio Giralt, Elihu H. Estey, Michael J. Keating, Moshe Talpaz, Miloslav Beran, Steven M. Kornblau, HM Kantarjian, O. Driessen and R. Willem and has published in prestigious journals such as Journal of Chromatography A, European Journal of Pharmacology and European Journal of Cancer.

In The Last Decade

D. De Vos

52 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. De Vos Netherlands	14	191	140	120	98	77	55	608
Laurine G. Galya United States	13	114 0.6×	99 0.7×	52 0.4×	50 0.5×	59 0.8×	20	479
David Good Canada	14	237 1.2×	154 1.1×	52 0.4×	104 1.1×	121 1.6×	35	1.2k
B.S. Potter United Kingdom	14	183 1.0×	121 0.9×	53 0.4×	78 0.8×	53 0.7×	60	688
Régis Leung-Toung Canada	18	519 2.7×	199 1.4×	47 0.4×	73 0.7×	30 0.4×	24	827
René Lattmann Switzerland	11	146 0.8×	227 1.6×	164 1.4×	72 0.7×	27 0.4×	17	665
M. H. Freedman Canada	12	103 0.5×	377 2.7×	54 0.5×	106 1.1×	151 2.0×	29	740
F. Taketa United States	19	115 0.6×	277 2.0×	39 0.3×	111 1.1×	77 1.0×	55	837
A. B. Robins United Kingdom	16	157 0.8×	312 2.2×	41 0.3×	260 2.7×	40 0.5×	42	631
Toshiya Suzuki Japan	22	132 0.7×	512 3.7×	133 1.1×	117 1.2×	49 0.6×	82	1.2k
Göran Claeson United Kingdom	21	367 1.9×	404 2.9×	423 3.5×	165 1.7×	89 1.2×	49	1.5k

Countries citing papers authored by D. De Vos

Since Specialization

Citations

This map shows the geographic impact of D. De Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. De Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. De Vos more than expected).

Fields of papers citing papers by D. De Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. De Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. De Vos. The network helps show where D. De Vos may publish in the future.

Co-authorship network of co-authors of D. De Vos

This figure shows the co-authorship network connecting the top 25 collaborators of D. De Vos. A scholar is included among the top collaborators of D. De Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. De Vos. D. De Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vos, D. De, et al.. (2024). IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis. Neoplasia. 50. 100981–100981. 9 indexed citations

Stockis, Armel, P. J. M. Guelen, & D. De Vos. (2002). Identification of mebeverine acid as the main circulating metabolite of mebeverine in man. Journal of Pharmaceutical and Biomedical Analysis. 29(1-2). 335–340. 17 indexed citations

Wolters, J., et al.. (1998). SYNTHESIS AND MULTINUCLEAR NMR PROPERTIES OF COMPOUNDS OF THE TYPE (C6H5)3PbR (R = ALKYL, ALKENYL, ALKYNYL). Main Group Metal Chemistry. 21(1). 55–64. 2 indexed citations

Goedhart, Dick, et al.. (1998). Clinical efficacy and safety of beclomethasone dipropionate inhalation capsules inhaled by Cyclohaler compared with Becotide Rotacaps inhaled by Rotahaler.. PubMed. 36(9). 510–5. 1 indexed citations

Wolters, J., et al.. (1997). SYNTHESIS AND MULTINUCLEAR NMR PROPERTIES OF SIXMEMBERED HETEROCYCLIC ORGANOLEAD COMPOUNDS. Main Group Metal Chemistry. 20(1). 37–46. 2 indexed citations

Kantarjian, HM, Michael J. Keating, Miloslav Beran, et al.. (1997). Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia. Leukemia. 11(10). 1617–1620. 115 indexed citations

Wagener, D. J. Theo, et al.. (1995). Antitumour activity and retinotoxicity of ethyldeshydroxy-sparsomycin in mice. European Journal of Cancer. 31(9). 1526–1530. 2 indexed citations

Wagener, D. J. Th., et al.. (1995). Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agents. Anti-Cancer Drugs. 6(2). 277–284. 1 indexed citations

Wagener, D. J. Th., et al.. (1995). Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin. Investigational New Drugs. 13(1). 23–32. 5 indexed citations

10.

Jenkins, Paul R., et al.. (1991). Structure of 2'-deoxy-5-azacytidine (decitabine) monohydrate. Acta Crystallographica Section C Crystal Structure Communications. 47(7). 1418–1420. 4 indexed citations

11.

Neijt, J.P., et al.. (1989). The bioavailability of three altretamine formulations. Pharmacy World & Science. 11(6). 218–223. 4 indexed citations

12.

Slee, P. H. Th. J., D. De Vos, Daniel P. Chapman, & D. Stevenson. (1988). The bioavailability of Tamoplex® (tamoxifen). Pharmacy World & Science. 10(1). 22–25. 8 indexed citations

13.

Stevenson, D., et al.. (1988). Determination of tamoxifen and five metabolites in plasma. Journal of Pharmaceutical and Biomedical Analysis. 6(6-8). 1065–1068. 19 indexed citations

14.

Wolters, J. & D. De Vos. (1984). Lead. Journal of Organometallic Chemistry. 274(1-3). 211–239. 1 indexed citations

15.

Vos, D. De, et al.. (1981). An Ultra‐Sensitive Microbiological Method for the Semi‐Quantitative Detection of Low‐Level Sulfonamides. Journal of Food Science. 46(1). 158–160. 6 indexed citations

16.

Vos, D. De, et al.. (1980). ¹H and ¹³C NMR investigations on alkyllead (iv) compounds. Bulletin des Sociétés Chimiques Belges. 89(10). 791–796. 4 indexed citations

17.

Vos, D. De & J. Wolters. (1978). Aromatic lead(IV) compounds IX: ¹³C‐FT‐NMR spectroscopy of compounds of the type Ar₄Pb. Recueil des Travaux Chimiques des Pays-Bas. 97(7-8). 219–220. 15 indexed citations

18.

Driessen, O., et al.. (1978). Adsorption of Fluorouracil on Glass Surfaces. Journal of Pharmaceutical Sciences. 67(10). 1494–1495. 13 indexed citations

19.

Vos, D. De, J. Wolters, & A. VAN DER GEN. (1973). Aromatic lead(IV) compounds. V: Direct plumbylation of monohalogen‐substituted benzenes: (Preliminary communication). Recueil des Travaux Chimiques des Pays-Bas. 92(7). 701–704. 7 indexed citations

20.

Vos, D. De & J. Wolters. (1972). Aromatic lead(IV) compounds II. PMR spectroscopy of some aryllead tricarboxylates. Journal of Organometallic Chemistry. 39(2). C63–C65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact